Wednesday, Oct 4, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Health | Studies Throw Light On How Tb Destroys Lungs And How To Protect Them

Studies throw light on how TB destroys lungs and how to protect them

Tuberculosis (TB) is a lung infection that has killed more humans than any other and until last year was the top infectious killer around the world. Globally, an estimated 10 million people develop the disease each year.

By ANI
Updated On - 12:11 PM, Wed - 16 June 21
Studies throw light on how TB destroys lungs and how to protect them
Representational Image
whatsapp facebook twitter telegram

Washington: The findings of two new studies have thrown unprecedented light on disease processes in tuberculosis, identifying key genetic changes that cause damage in the lungs and drug treatment that could speed up recovery.

Tuberculosis (TB) is a lung infection that has killed more humans than any other and until last year was the top infectious killer around the world. Globally, an estimated 10 million people develop the disease each year. The findings are reported in two papers in the Journal of Clinical Investigation.

In the first study, a team from the University of Southampton used a new 3D culture system they have developed to observe the changes that occur in cells infected with TB. Unlike the laboratory-standard 2D culture system, where cells are placed in a flat plastic dish, the 3D system uses an engineering technique to suspend them in droplets – like frogspawn. The team found that the TB-infected cells in droplets responded very closely to cells in the lungs of patients with the disease.

This observation has widespread implications for further studies into infectious diseases, including COVID-19.

A second team from the University of Southampton then carried out complex sequencing techniques on the cells to identify the events through which TB causes excessive inflammation and damage to the lung.

Human genome sequencing methods generate information on tens of thousands of changes in genes from each sample, making it difficult to work out which changes are important and which are from chance. The Southampton Systems Immunology Group combined different mathematical approaches, such as clustering algorithms, to whittle this down to seven genes which seem to underpin the lung destruction that occurs in TB.

Dr Michaela Reichmann of the University of Southampton who conducted the study said “The integration of modern sequencing techniques with clinical samples is permitting unprecedented insight into disease mechanisms, while our 3D cell culture system then lets us replicate conditions in patients and identify new treatment approaches.”

In the second study, a clinical trial led by Dr Catherine Ong of the National University of Singapore studied the use of a common antibiotic, doxycycline, to reverse these changes. The phase 2 double-blind trial in 30 patients showed that doxycycline, in combination with TB drug treatment, reduces the size of lung cavities and accelerates markers of lung recovery towards health. These bioinformatics analyses were performed by the Systems Immunology Group in Southampton.

The treatment was found to be safe, with similar side effects to those experienced by patients on placebo pills. The study shows promise in delivering a new standard of care that can potentially prevent long-term complications.

Dr Ong said “Pulmonary TB patients tend to suffer from lung damage after TB, which is associated with mortality, and poorer quality of life. Doxycycline is a cheap and widely available antibiotic that can decrease lung damage, and potentially improve quality of life for these patients.”

The team now are seeking funds for a fully-powered larger-scale phase 3 trial to verify these findings.

The international team is also aiming to translate these new insights into approaches that may shorten treatment from the current minimum of six months and improve treatment of drug-resistant disease, which is progressively increasing.

The clinical trial was based on a collaboratory network involving the National University of Singapore, the University of Southampton, and St George’s London, while the basic science study also involved the African Health Research Institute, Durban, and Yale and Colombia Universities in the United States.

Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • drug treatment
  • genetic
  • Lungs
  • Tuberculosis

Related News

  • Uttar Pradesh: Rs 2.78 lakh paid to TB patients for nutritious food till September 17 this year

    Uttar Pradesh: Rs 2.78 lakh paid to TB patients for nutritious food till September 17 this year

  • Global leaders pledge to eradicate tuberculosis by 2030 in UN Summit

    Global leaders pledge to eradicate tuberculosis by 2030 in UN Summit

  • Scientists create robot for navigating living lung tissue

    Scientists create robot for navigating living lung tissue

  • Editorial: Surge in TB cases

    Editorial: Surge in TB cases

  • New rapid blood test to detect 18 infectious, inflammatory diseases in kids

    New rapid blood test to detect 18 infectious, inflammatory diseases in kids

  • Study finds how people with low levels of vitamin K have less healthy lungs

    Study finds how people with low levels of vitamin K have less healthy lungs

Latest News

  • Mehreen Pirzada channels Audrey & Marilyn Monroe vibes in ‘Sultan of Delhi’

    3 mins ago
  • ‘Ambedkar Reading Sessions’ at KBR Park to foster anti-caste awareness

    13 mins ago
  • Health Crisis In Andhra Pradesh: Rapid Spread Of Malaria And Dengue | Praja Arogya Vedika

    23 mins ago
  • CWC: New Zealand gear up for opener against England in Ahmedabad; players sweat in net practice

    33 mins ago
  • Rajinikanth’s first look from ‘Thalaivar 170’ out now

    43 mins ago
  • Indian Air Force receives first LCA Tejas trainer aircraft from HAL

    58 mins ago
  • Bengal school jobs scam: ED summons TMC’s Abhishek Banerjee on Oct 9

    1 hour ago
  • Gmail to enforce strict rules in 2024 to keep your inbox spam-free

    1 hour ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam